ADVANCED CELL TECHNOLOGY, INC. 4
4 · ADVANCED CELL TECHNOLOGY, INC. · Filed Sep 11, 2014
Insider Transaction Report
Form 4
Lanza Robert
Chief Scientific Officer
Transactions
- Sale
Common Stock
2014-09-10$12.57/sh−3,930$49,400→ 175,509 total - Sale
Common Stock
2014-09-10$12.50/sh−5,000$62,500→ 179,439 total
Footnotes (1)
- [F1]Shares sold pursuant to a 10b5-1 Plan.